Cas:77916-78-0 2-methyl-3-phenylpropan-1-amine manufacturer & supplier

Chemical Name:2-methyl-3-phenylpropan-1-amine

CAS.NO:77916-78-0

Synonyms:2-methyl-3-phenylpropylamine;2-Methyl-3-phenyl-propylamin;2-methyl-3-phenyl-1-propylamine;Benzenepropanamine,b-methyl

Molecular Formula:C₁₀H₁₅N

Molecular Weight:149.23300

HS Code:2921499090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:229.819ºC at 760 mmHg

Density:0.937g/cm3

Index of Refraction:1.522

PSA:26.02000

Exact Mass:149.12000

LogP:2.52420

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-methyl-3-phenylpropylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenepropanamine,b-methyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-methyl-3-phenyl-1-propylamine Use and application,2-methyl-3-phenylpropylamine technical grade,usp/ep/jp grade.

Related News: Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching. 2-methyl-3-phenylpropan-1-amine manufacturer A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643). 2-methyl-3-phenylpropan-1-amine supplier Innova’s kit includes a nasal swab and a lateral flow test strip, which in less than a half-hour produces colored lines to display a positive reading, similar to a pregnancy test. However, the FDA said that false-negative and false-positive results may lead to delayed diagnoses, inappropriate treatment and the further spread of the virus. 2-methyl-3-phenylpropan-1-amine vendor This is called API. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine. 2-methyl-3-phenylpropan-1-amine factory Darzalex does have another regimen approved for the same myeloma population. Darzalex combined with Takeda’s Velcade, melphalan and prednisone (VMP) reduced the risk of death by 40% in the phase 3 ALCYONE trial. But disease progression had already occurred in half of patients on the Darzalex-VMP combo after about three years of follow-up, a much shorter period than the five-year mark the Darzalex-Rd regimen is approaching.